Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Lymphocytic Leukemia Acalabrutinibfor the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients Wit ...
A Phase 2 Trial of Acalabrutinib for the Treatment of Relapsed/Refractory Autoimmune Hemolytic Anemia A Phase 2 Trial of Acalabrutinibfor the Treatment of Relapsed/Refractory Autoimmune Hemolytic Anemia ...